FFCP PHASE1:Mm9::chrX:133893233..133893244,+: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=NA|HGNC=|MCL_coexpression_id=146|UniProt=NA|association_with_transcript=NA|description=CAGE_peak_at_chrX:133893233..133893244,+|id=chrX:133893233..133893244,+|ontology_enrichment_celltype=CL:0000107!5.67e-24!9;CL:0000540!3.98e-07!33;CL:0000047!3.98e-07!33;CL:0000031!3.98e-07!33;CL:0000404!3.98e-07!33|ontology_enrichment_celltype_v019_2=|ontology_enrichment_disease=|ontology_enrichment_disease_v019_2=|ontology_enrichment_uberon=UBERON:0002342!1.06e-35!10;UBERON:0005062!1.06e-35!10;UBERON:0002369!8.74e-26!7;UBERON:0006858!8.74e-26!7;UBERON:0002410!5.67e-24!9;UBERON:0000010!2.09e-19!11;UBERON:0003064!2.00e-12!14;UBERON:0005157!4.36e-12!27;UBERON:0002005!2.02e-11!3;UBERON:0005428!2.02e-11!3;UBERON:0000013!2.37e-11!3|ontology_enrichment_uberon_v019_2=UBERON:0002369,1.76e-56,7;UBERON:0006858,1.76e-56,7;UBERON:0003064,2.02e-28,14;UBERON:0005256,6.28e-09,45;UBERON:0005172,3.37e-08,49;UBERON:0005173,3.37e-08,49;UBERON:0002417,3.37e-08,49;UBERON:0000916,3.37e-08,49|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.255129870453209,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.15279824777681,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11.1331604298619,0.693941307064543,3.34912026143355,3.22861696158482,4.97384713823654,3.76283862834255,2.51333182659351,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.114248512609729,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.631016438832513,0.780877488593277,1.50796378412959,0.238968797952552,0.222798674082394,0,0.404810701674894,1.16902343164525,0.790575555893047,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.56369293868419,0,0,0.194451188344048,0,0,0,0,0,0.724752362478018,0.288030006257865,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.222246727801615,0.206035057238894,0,0,0,0,0,0.128050304809739,0.0574354689556133,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0|short_description=p@chrX:133893233..133893244,+}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=NA | |||
|HGNC= | |||
|MCL_coexpression_id=146 | |||
|TSSclassifier=NA | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|cluster_id=chrX:133893233..133893244,+ | |||
|description=CAGE_peak_at_chrX:133893233..133893244,+ | |||
|id=chrX:133893233..133893244,+ | |||
|ontology_enrichment_celltype=CL:0000107!5.67e-24!9;CL:0000540!3.98e-07!33;CL:0000047!3.98e-07!33;CL:0000031!3.98e-07!33;CL:0000404!3.98e-07!33 | |||
|ontology_enrichment_celltype_v019_2= | |||
|ontology_enrichment_disease= | |||
|ontology_enrichment_disease_v019_2= | |||
|ontology_enrichment_uberon=UBERON:0002342!1.06e-35!10;UBERON:0005062!1.06e-35!10;UBERON:0002369!8.74e-26!7;UBERON:0006858!8.74e-26!7;UBERON:0002410!5.67e-24!9;UBERON:0000010!2.09e-19!11;UBERON:0003064!2.00e-12!14;UBERON:0005157!4.36e-12!27;UBERON:0002005!2.02e-11!3;UBERON:0005428!2.02e-11!3;UBERON:0000013!2.37e-11!3 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0002369,1.76e-56,7;UBERON:0006858,1.76e-56,7;UBERON:0003064,2.02e-28,14;UBERON:0005256,6.28e-09,45;UBERON:0005172,3.37e-08,49;UBERON:0005173,3.37e-08,49;UBERON:0002417,3.37e-08,49;UBERON:0000916,3.37e-08,49 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.255129870453209,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.15279824777681,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11.1331604298619,0.693941307064543,3.34912026143355,3.22861696158482,4.97384713823654,3.76283862834255,2.51333182659351,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.114248512609729,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.631016438832513,0.780877488593277,1.50796378412959,0.238968797952552,0.222798674082394,0,0.404810701674894,1.16902343164525,0.790575555893047,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.56369293868419,0,0,0.194451188344048,0,0,0,0,0,0.724752362478018,0.288030006257865,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.222246727801615,0.206035057238894,0,0,0,0,0,0.128050304809739,0.0574354689556133,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p@chrX:133893233..133893244,+ | |||
}} |
Latest revision as of 00:44, 6 August 2015
Short description: | p@chrX:133893233..133893244, + |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_at_chrX:133893233..133893244, + |
Coexpression cluster: | MCL_coexpression_mm9:146 |
Association with transcript: | NA |
EntrezGene: | NA |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
adrenal gland | 1.76e-56 | 7 |
adrenal/interrenal gland | 1.76e-56 | 7 |
intermediate mesoderm | 2.02e-28 | 14 |
trunk mesenchyme | 6.28e-09 | 45 |
abdomen element | 3.37e-08 | 49 |
abdominal segment element | 3.37e-08 | 49 |
abdominal segment of trunk | 3.37e-08 | 49 |
abdomen | 3.37e-08 | 49 |